NO144147C - Analogifremgangsmaate for fremstilling av farmakologisk aktive prostaglandinderivater - Google Patents
Analogifremgangsmaate for fremstilling av farmakologisk aktive prostaglandinderivaterInfo
- Publication number
- NO144147C NO144147C NO760994A NO760994A NO144147C NO 144147 C NO144147 C NO 144147C NO 760994 A NO760994 A NO 760994A NO 760994 A NO760994 A NO 760994A NO 144147 C NO144147 C NO 144147C
- Authority
- NO
- Norway
- Prior art keywords
- ingrediates
- prostagland
- preparation
- pharmacologically active
- analogy procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/45—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
- C07C49/04—Saturated compounds containing keto groups bound to acyclic carbon atoms
- C07C49/16—Saturated compounds containing keto groups bound to acyclic carbon atoms containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
- C07C51/377—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
- C07C51/38—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups by decarboxylation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/185—Saturated compounds having only one carboxyl group and containing keto groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
- C07F1/005—Compounds containing elements of Groups 1 or 11 of the Periodic Table without C-Metal linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5407—Acyclic saturated phosphonium compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB12034/75A GB1529852A (en) | 1975-03-21 | 1975-03-21 | 8-azaprostaglandins and process for the preparation thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
NO760994L NO760994L (ru) | 1976-09-22 |
NO144147B NO144147B (no) | 1981-03-23 |
NO144147C true NO144147C (no) | 1981-07-15 |
Family
ID=9997230
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO760994A NO144147C (no) | 1975-03-21 | 1976-03-19 | Analogifremgangsmaate for fremstilling av farmakologisk aktive prostaglandinderivater |
Country Status (26)
Country | Link |
---|---|
JP (1) | JPS607602B2 (ru) |
AR (1) | AR213172A1 (ru) |
AT (1) | AT348163B (ru) |
AU (1) | AU501105B2 (ru) |
BE (1) | BE839761A (ru) |
CA (1) | CA1076587A (ru) |
CH (2) | CH611881A5 (ru) |
DE (1) | DE2612114A1 (ru) |
DK (1) | DK140937B (ru) |
ES (2) | ES446239A1 (ru) |
FI (1) | FI61692C (ru) |
FR (1) | FR2304340A1 (ru) |
GB (1) | GB1529852A (ru) |
HU (1) | HU173348B (ru) |
IE (1) | IE42966B1 (ru) |
IT (1) | IT1061011B (ru) |
MX (1) | MX3301E (ru) |
NL (1) | NL7602891A (ru) |
NO (1) | NO144147C (ru) |
NZ (1) | NZ180251A (ru) |
OA (1) | OA05279A (ru) |
PT (1) | PT64919B (ru) |
SE (1) | SE418290B (ru) |
SU (1) | SU614746A3 (ru) |
YU (1) | YU73876A (ru) |
ZA (1) | ZA761448B (ru) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4097489A (en) * | 1977-06-17 | 1978-06-27 | The Upjohn Company | 9-Deoxy-9α,6-nitrilo or 6,9α-imino-PGF compounds |
US5540618A (en) * | 1994-10-28 | 1996-07-30 | National University Of Singapore | Passive attenuator for shelter protection against explosions |
WO2003074483A1 (fr) | 2002-03-05 | 2003-09-12 | Ono Pharmaceutical Co., Ltd. | Composes derives de 8 azaprostaglandine et medicaments contenant ceux-ci comme principe actif |
-
1975
- 1975-03-21 GB GB12034/75A patent/GB1529852A/en not_active Expired
-
1976
- 1976-03-02 DK DK88276AA patent/DK140937B/da not_active IP Right Cessation
- 1976-03-09 ZA ZA761448A patent/ZA761448B/xx unknown
- 1976-03-09 NZ NZ180251A patent/NZ180251A/xx unknown
- 1976-03-11 AU AU11899/76A patent/AU501105B2/en not_active Expired
- 1976-03-15 IE IE545/76A patent/IE42966B1/en unknown
- 1976-03-17 AT AT195676A patent/AT348163B/de not_active IP Right Cessation
- 1976-03-18 IT IT21346/76A patent/IT1061011B/it active
- 1976-03-18 SE SE7603400A patent/SE418290B/xx unknown
- 1976-03-18 FR FR7607794A patent/FR2304340A1/fr active Granted
- 1976-03-18 PT PT64919A patent/PT64919B/pt unknown
- 1976-03-19 CH CH844678A patent/CH611881A5/xx not_active IP Right Cessation
- 1976-03-19 YU YU00738/76A patent/YU73876A/xx unknown
- 1976-03-19 AR AR262630A patent/AR213172A1/es active
- 1976-03-19 CH CH350176A patent/CH611604A5/xx not_active IP Right Cessation
- 1976-03-19 BE BE165326A patent/BE839761A/xx not_active IP Right Cessation
- 1976-03-19 CA CA248,275A patent/CA1076587A/en not_active Expired
- 1976-03-19 HU HU76LA885A patent/HU173348B/hu unknown
- 1976-03-19 FI FI760744A patent/FI61692C/fi not_active IP Right Cessation
- 1976-03-19 SU SU762334454A patent/SU614746A3/ru active
- 1976-03-19 NL NL7602891A patent/NL7602891A/xx not_active Application Discontinuation
- 1976-03-19 NO NO760994A patent/NO144147C/no unknown
- 1976-03-19 MX MX000100U patent/MX3301E/es unknown
- 1976-03-20 ES ES446239A patent/ES446239A1/es not_active Expired
- 1976-03-20 OA OA55774A patent/OA05279A/xx unknown
- 1976-03-22 DE DE19762612114 patent/DE2612114A1/de not_active Withdrawn
- 1976-03-22 JP JP51031889A patent/JPS607602B2/ja not_active Expired
-
1977
- 1977-05-03 ES ES458389A patent/ES458389A1/es not_active Expired
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO145199C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive nortropinestere. | |
NO147450C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolonderivater | |
NO149106C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive benzcykloamider | |
NO148813C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive karbostyrilderivater | |
SE433208B (sv) | Forfarande for framstellning av fenoletrar | |
SE431088B (sv) | Forfarande for framstellning av terapeutiskt verksamma benshydrylsulfinylderivat | |
NO141411C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive erytromycin-derivater | |
NO145379C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n2-arylsulfonyl-l-argininamider. | |
NO145792C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive pyrimidon-derivater | |
NO151040C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-halogenpyrimid-2-oner | |
SE431544B (sv) | Analogiforfarande for framstellning av farmakologiskt aktiva 4-pyrimidon-derivat | |
NO146095C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive kinazolin-derivater | |
NO145842C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive indolizinderivater | |
NO143796C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme piperazinyliminorifamyciner | |
NO145762C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive antracyklinglykosidiske forbindelser | |
NO146359C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive cyproheptadinderivater | |
NO141894C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridobenzodiazepinoner | |
NO146022C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme benzofenonderivater | |
NO149388C (no) | Analogi-fremgangsmaate for fremstilling av farmakologisk aktive karbostyril-derivater | |
NO148454C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidin-dionderivater | |
SE427839B (sv) | Analogiforfaranden for framstellning av n-aryl-n-(1-l-4-piperidinyl)-aryl-acetamider | |
NO145950C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive homoftalimider | |
NO142524C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive cykloheksylfenyl-derivater | |
NO143903C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater | |
NO145197C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive morfolinforbindelser |